Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_assertion type Assertion NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_head.
- NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_assertion wasGeneratedBy ECO_0000203 NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_provenance.
- NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_assertion wasDerivedFrom befree-20140225 NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_provenance.
- NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_assertion SIO_000772 11567226 NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_provenance.
- NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_assertion evidence source_evidence_literature NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_provenance.
- NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_assertion description "[To determine whether this was the case in posttransplant lymphoproliferative disease (PTLD) and related disorders, we used immunohistochemistry to analyze expression of TRAF1 in a total of 42 such lesions arising in a variety of immunosuppressive states.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264358.RAijCW_rlT_YN_GLxq_0e-JUeNCF2ozZtdvVOT_87I_vo130_provenance.